Abstract
A rapid and reliable radioreceptor assay for measuring endogenous opiate peptides in human CSF and plasma has been developed. The method is based on the competition between [ 3H]-[D-Ala 2]enkephalin-(L-leu-amide) 5 and biologically active opioids for binding sites using crude rat brain membranes. Sensitivity is about 250 fmol/ml sample; 100 μl of plasma or CSF inhibit the total binding within the range of 25-75%. At therapeutic concentrations, psychotropic drugs do not interfere with the assay. Elution profiles of CSF and plasma show two major peaks, probably representing endorphin-like and enkephalin-like compounds. Normal levels, expressed in β-endorphin-like activity, are 1.4-4.8 pmol/ml for extracted plasma and 7.1-15.8 pmol/ml for CSF.
Original language | English (US) |
---|---|
Pages (from-to) | 83-91 |
Number of pages | 9 |
Journal | Substance and Alcohol Actions/Misuse |
Volume | 1 |
Issue number | 1 |
State | Published - 1980 |
Externally published | Yes |
ASJC Scopus subject areas
- General Medicine